Probir Kumar Ojha
Probir Kumar Ojha
Research Scholar, Jadavpur University
Verified email at
Cited by
Cited by
Further exploring rm2 metrics for validation of QSPR models
PK Ojha, I Mitra, RN Das, K Roy
Chemometrics and Intelligent Laboratory Systems 107 (1), 194-205, 2011
Comparative studies on some metrics for external validation of QSPR models
K Roy, I Mitra, S Kar, PK Ojha, RN Das, H Kabir
Journal of chemical information and modeling 52 (2), 396-408, 2012
Some case studies on application of “rm2” metrics for judging quality of quantitative structure–activity relationship predictions: emphasis on scaling of response data
K Roy, P Chakraborty, I Mitra, PK Ojha, S Kar, RN Das
Journal of computational chemistry 34 (12), 1071-1082, 2013
Comparative QSARs for antimalarial endochins: importance of descriptor-thinning and noise reduction prior to feature selection
PK Ojha, K Roy
Chemometrics and Intelligent Laboratory Systems 109 (2), 146-161, 2011
On further application of r as a metric for validation of QSAR models
I Mitra, PP Roy, S Kar, PK Ojha, K Roy
Journal of Chemometrics: A Journal of the Chemometrics Society 24 (1), 22-33, 2010
Introduction of rm2 (rank) metric incorporating rank-order predictions as an additional tool for validation of QSAR/QSPR models
K Roy, I Mitra, PK Ojha, S Kar, RN Das, H Kabir
Chemometrics and Intelligent Laboratory Systems 118, 200-210, 2012
Is it possible to improve the quality of predictions from an “intelligent” use of multiple QSAR/QSPR/QSTR models?
K Roy, P Ambure, S Kar, PK Ojha
Journal of Chemometrics 32 (4), e2992, 2018
Chemometric modeling, docking and in silico design of triazolopyrimidine-based dihydroorotate dehydrogenase inhibitors as antimalarials
PK Ojha, K Roy
European journal of medicinal chemistry 45 (10), 4645-4656, 2010
Diacerein-mediated inhibition of IL-6/IL-6R signaling induces apoptotic effects on breast cancer
R Bharti, G Dey, PK Ojha, S Rajput, SK Jaganathan, R Sen, M Mandal
Oncogene 35 (30), 3965-3975, 2016
Development of CoMFA and CoMSIA models of cytotoxicity data of anti-HIV-1-phenylamino-1H-imidazole derivatives
A Basu, K Jasu, V Jayaprakash, N Mishra, P Ojha, S Bhattacharya
European journal of medicinal chemistry 44 (6), 2400-2407, 2009
Effect of Carriers on Solid Dispersions of Simvastatin (Sim): PhysicoChemical Characterizations and Dissolution Studies
LKG Dipika Mandal, Probir Kumar Ojha, Bankim Chandra
Der Pharmacia Lettre 2 (4), 47-56, 2010
Development of a robust and validated 2D-QSPR model for sweetness potency of diverse functional organic molecules
PK Ojha, K Roy
Food and Chemical Toxicology 112, 551-562, 2018
Therapeutics for COVID-19: from computation to practices—where we are, where we are heading to
PK Ojha, S Kar, JG Krishna, K Roy, J Leszczynski
Molecular diversity 25 (1), 625-659, 2021
Discovery of mixed type thymidine phosphorylase inhibitors endowed with antiangiogenic properties: Synthesis, pharmacological evaluation and molecular docking study of 2-thioxo …
GNCC Hriday Bera, Probir Kumar Ojha, Bee Jen Tan, Lingyi Sun, Anton V ...
European Journal of Medicinal Chemistry 78, 294-303, 2014
Therapeutic implication of ‘Iturin A’for targeting MD-2/TLR4 complex to overcome angiogenesis and invasion
G Dey, R Bharti, PK Ojha, I Pal, Y Rajesh, I Banerjee, P Banik, S Parida, ...
Cellular signalling 35, 24-36, 2017
Predictive quantitative structure–property relationship (QSPR) modeling for adsorption of organic pollutants by carbon nanotubes (CNTs)
J Roy, S Ghosh, PK Ojha, K Roy
Environmental Science: Nano 6 (1), 224-247, 2019
Advances in quantitative structure–activity relationship models of antimalarials
K Roy, PK Ojha
Expert opinion on drug discovery 5 (8), 751-778, 2010
Chemometric modelling of antimalarial activity of aryltriazolylhydroxamates
PK Ojha, K Roy
Molecular Simulation 36 (12), 939-952, 2010
Multilayered variable selection in QSPR: a case study of modeling melting point of bromide ionic liquids
S Das, PK Ojha, K Roy
International Journal of Quantitative Structure-Property Relationships …, 2017
Exploring QSAR, pharmacophore mapping and docking studies and virtual library generation for cycloguanil derivatives as PfDHFR-TS inhibitors
P Kumar Ojha, K Roy
Medicinal Chemistry 7 (3), 173-199, 2011
The system can't perform the operation now. Try again later.
Articles 1–20